The relationship between glutamate release and cerebral blood flow after focal cerebral ischaemia in the cat: Effect of pretreatment with enadoline (a kappa receptor agonist)

Brain Research

Volumn 712, Issue 2, 1996, Pages 329-334

  MacKay, K B ^a,c   Patel, T R ^c   Galbraith, S L ^c   Woodruff, G N ^b,c   McCulloch, J ^c  

^a GLAXOSMITHKLINE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

cerebral blood flow; cerebral ischaemia; excitotoxicity; glutamate; microdialysis; neuroprotection; opioid agonist

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; ENADOLINE; GLUTAMIC ACID; KAPPA OPIATE RECEPTOR; NEUROPROTECTIVE AGENT; OPIATE AGONIST;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN ISCHEMIA; CAT; CONTROLLED STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MICRODIALYSIS; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029997225     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01559-0     Document Type: Article

References (36)

1. Baskin, D.S., Widmayer, M.A., Browning, J.L., Heizer, M.L. and Schmidt, W.K., Evaluation of delayed treatment of focal cerebral ischemia with three selective κ-opioid agonists in cats, Stroke, 25 (1994) 2047-2054.
2. Butcher, S.P., Bullock, R., Graham, D.I. and McCulloch, J., Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion, Stroke, 21 (1990) 1727-1733.
3. DeCoster, M.A., Conover, J.R., Hunter, J.C. and Tortella, F.C., The neuroprotective κ-opioid CI-977 alters glutamate-induced calcium signaling in vitro, NeuroReport, 5 (1994) 2305-2310.
4. Fujisawa, H., Dawson, D., Browne, S.E., Mackay, K.B., Bullock, R. and McCulloch, J., Pharmacological modification of glutamate neurotoxicity in vivo, Brain Res., 629 (1993) 73-78.
5. Gannon, R.L. and Terrian, D.M., Kappa opioid agonists inhibit transmitter release from guinea pig hippocampal mossy fiber synaptosomes, Neurochem. Res., 17 (1992) 741-747.
6. Gill, R., The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/Kainate antagonists and their role in cerebral ischaemia, Cerebrovasc. Brain Metab. Rev., 6 (1994) 225-256.
7. Graham, S.H., Chen, J., Sharp, F.R. and Simon, R.P., Limiting ischemic injury by inhibition of excitatory amino acid release, J. Cereb. Blood Flow Metabol., 13 (1993) 88-97.
8. Graham, S.H., Chen, J., Lan, J., Leach, M.J. and Simon R.P., Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion, J. Pharmacol. Exp. Ther., 269 (1994) 854-859.
9. Gross, R.A. and Macdonald, R.L., Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurones in cell culture, Proc. Natl. Acad. Sci. USA, 84 (1987) 5469-5473.
10. Hayward, N.J., McKnight, A.T. and Woodruff, G.N., Neuroprotective effect of the κ-agonist enadoline (CI-977) in rat models of focal cerebral ischaemia, Eur. J. Neurosci., 5 (1993) 961-967.
11. Hayward, N.J., Hitchcott, P.K., McKnight, A.T. and Woodruff, G.N., Effect of enadoline on ischaemia-induced glutamate release, Brit. J. Pharmacol., 110 (1993) 62P.
12. Hill, M.P. and Brotchie, J.M., Modulation of glutamate release by a κ-opioid receptor agonist in rodent and primate striatum, Eur. J. Pharmacol., 281 (1995) R1-R2.
13. Katayama, Y., Kawamata, R., Tamura, T., Hovda, D.A., Becker, D.P. and Tsubokawa, T., Calcium-dependent glutamate release concomitant with massive potassium flux during cerebral ischemia in vivo, Brain Res., 558 (1991) 136-140.
14. Kusumoto, K., Mackay, K.B. and McCulloch, J., The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia, Brain Res., 576, (1992) 147-151.
15. Lambert, P.D., Woodruff, G.N., Hughes, J. and Hunter, J.C., Inhibition of L-glutamate release: a possible mechanism of action for the neuroprotective effects of the κ-selective agonist CI-977, Mol. Neuropharmacol., 1 (1991) 77-82.
16. Lindroth, P. and Mopper, K., High performance liquid chromatographic determination of subpicomole amounts of amino acid by precolumn fluorescence derivatization with δ-pthaldialdehyde, Anal. Chem., 51 (1979) 1667-1674.
17. Mackay, K.B., Kusumoto, K., Graham, D.I. and McCulloch, J., Focal cerebral ischemia in the cat: pretreatment with a kappa-1 opioid receptor agonist, CI-977, Brain Res., 618 (1993) 213-219.
18. Mackay, K.B., Kusumoto, K., Graham, D.I. and McCulloch, J., Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat, Brain Res., 629 (1993) 10-18.
19. Matsumoto, K., Graf, R., Rosner, G., Shimada, N. and Heiss, W.-D., Flow thresholds for extracellular purine catabolite elevation in cat focal ischemia, Brain Res., 579 (1992) 309-314.
20. Matsumoto, K., Graf, R., Rosner, G., Taguchi, J. and Heiss, W.-D., Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia, J. Cereb. Blood Flow Metabol., 13 (1993) 586-594.
21. McCulloch, J., Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man, Br. J. Clin. Pharmacol., 34 (1992) 106-114.
22. McCulloch, J. and Iversen, L.L., Autoradiographic assessment of the effects of N-methyl-D-aspartate (NMDA) receptor antagonists in vivo, Neurochem. Res., 16 (1991) 951-963.
23. Millan M. H., Chapman, A.G. and Meldrum, B.S., Dual inhibitory action of enadoline (CI977) on release of amino acids in the rat hippocampus, Eur. J. Pharmacol., 279 (1995) 75-81.
24. Muir, K.W. and Lees, K.R., Clinical experience with excitatory amino acid antagonist drugs, Stroke, 26 (1995) 505-513.
25. Nicholls, D. and Attwell, D., The release and uptake of excitatory amino acids, Trends Pharmacol. Sci., 11 (1990) 462-468.
26. Obrenovitch, T.P. and Richards, D.A., Extracellular neurotransmitter changes in cerebral ischemia, Cerebrovasc. Brain Metab. Rev., 7 (1995) 1-54.
27. Olney, J.W., Labruyere, J., Wang, G., Wozniak, D.F., Price, M.T. and Sesma, M.A., NMDA antagonist neurotoxicity: mechanism and prevention, Science, 254 (1991) 1515-1518.
28. Osborne, K.A., Shigeno, T., Balarsky, A.-M., Ford, I., McCulloch, J., Teasdale, G.M. and Graham, D.I., Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia, J. Neurol. Neurosurg. Psychiatry, 50 (1987) 402-410.
29. Pinnock, R.D., A highly selective κ-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro, Neuroscience, 47 (1992) 87-94.
30. Szatkowski, M. and Attwell, D., Triggering and execution of neuronal death in brain ischemia: two phases of glutamate release by different mechanisms, Trends Neurol. Sci., 17 (1994) 359-365.
31. Takagi, K., Ginsberg, M.D., Globus, M. Y.-T., Dietrich, W.D., Martinez, E., Kraydieh, S. and Busto, R., Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology, J. Cereb. Blood Flow Metab., 13 (1993) 575-585.
32. Takizawa, S., Matsushima, K., Fujita, H., Nanri, K., Ogawa, S. and Shinohara, Y., A selective N-type calcium channel antagonist reduces glutamate release and infarct volume in focal cerebral ischemia, J. Cereb. Blood Flow Metab., 15 (1995) 611-618.
33. Wahl, W., Obrenovitch, T.P., Hardy, A.M., Plotkine, M., Boulu, R. and Symon, L., Extracellular glutamate during focal cerebral ischaemia in rats: time course and calcium dependency, J. Neurochem., 63 (1994) 1003-1011.
34. Willetts, J., Balster, R.L. and Leander, J.D., The behavioral pharmacology of NMDA receptor antagonists, Trends Pharmacol. Sci., 11 (1990) 423-428.
35. 45Ca into rat cortical synaptosomes by inhibiting N-but not L-type calcium channels, Neuropharmacology, 29 (1990) 439-444.
36. 2 clearance measurement of blood flow: A review of technique and polargraphic principles, Stroke, 11 (1980) 552-564.